Episode 21

full
Published on:

15th Jul 2021

The Cannabinoid Opportunity for Cosmetics & Pharma

Cannabinoids have caught the attention of Pharma and Cosmetic companies alike in recent years, celebrated for their anti-inflammatory, anti-oxidant and anti-bacterial properties in cosmetic products, and neurological and chronic pain benefits on the pharma side.

There is also rising consumer demand for cannabinoids, exacerbated by a shift towards ‘natural’ and toxin free products, which present an interesting opportunity for ingredient manufacturers and producers.

In this podcast we speak to Dr. Monica Vialpando, founder and CEO of Via Innovations about the promising applications of cannabinoids, the innovative approaches to product development and formulation, and examining the regulatory and legal considerations of bringing these products to market and whether there is an opportunity for pharma companies to diversify into the cosmetics market.

Listen for free

Show artwork for CPhI Podcast Series

About the Podcast

CPhI Podcast Series
Your new monthly pharma soundbite
The CPHI Podcast Series is your new monthly pharma soundbite, bringing you insights from across the global value chain. Through drug discovery and development to manufacturing and delivery, we’ll bring you impactful content to keep you informed on the latest trends, developments, and opportunities in Pharma.

Brought to you by the organisers of the CPhI and Pharmapack exhibitions, the series is an easy way to stay up to date on the issues which matter to your business. Tune in to hear from key industry stakeholders sharing easy-to-digest insights – the CPhI Podcast Series is your trusted voice in pharma.

About your host

Profile picture for Tara Dougal

Tara Dougal